Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 15.54M
March 31, 2026 -1.80M
December 31, 2025 -2.046M
September 30, 2025 194.65M
June 30, 2025 -2.834M
March 31, 2025 40.53M
December 31, 2024 115.99M
September 30, 2024 247.78M
June 30, 2024 -7.162M
March 31, 2024 -4.395M
December 31, 2023 -1.418M
September 30, 2023 -3.572M
June 30, 2023 -5.491M
March 31, 2023 -7.717M
December 31, 2022 -7.872M
September 30, 2022 -4.682M
June 30, 2022 108.50M
March 31, 2022 -4.903M
December 31, 2021 -8.679M
September 30, 2021 54.58M
June 30, 2021 -8.842M
March 31, 2021 -1.106M
December 31, 2020 -6.744M
September 30, 2020 5.501M
June 30, 2020 -11.46M
Date Value
March 31, 2020 -5.619M
December 31, 2019 -3.756M
September 30, 2019 -2.191M
June 30, 2019 -3.191M
March 31, 2019 -4.132M
December 31, 2018 -2.882M
September 30, 2018 -11.57M
June 30, 2018 -6.52M
March 31, 2018 -5.146M
December 31, 2017 -13.95M
September 30, 2017 -16.30M
June 30, 2017 -9.97M
March 31, 2017 -6.442M
December 31, 2016 -6.479M
September 30, 2016 19.49M
June 30, 2016 -23.65M
March 31, 2016 -10.06M
December 31, 2015 -7.937M
September 30, 2015 7.174M
June 30, 2015 -98.10M
March 31, 2015 -0.363M
December 31, 2014 -0.799M
September 30, 2014 -1.545M
June 30, 2014 -3.067M
March 31, 2014 -0.264M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. -134.00M
Labcorp Holdings, Inc. -366.20M
Psychemedics Corp. --
NeoGenomics, Inc. -8.319M
First Choice Healthcare Solutions, Inc. 0.00